Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug‐eluting stent implantations

Validation of contemporary risk scores in predicting coronary thrombotic events and major... AbbreviationsACSacute coronary syndromeCTEcoronary thrombotic eventsDAPTdual‐antiplatelet therapyMACEmajor adverse cardiovascular eventsMACCEmajor adverse cardiac and cerebral eventsMBmajor bleedingNSTEMInon‐ST‐segment elevation myocardial infarctionPCIpercutaneous coronary interventionSTstent thrombosisSTEMIST‐segment elevation myocardial infarctionINTRODUCTIONDual‐antiplatelet therapy (DAPT) with aspirin plus a P2Y12 inhibitor reduces thrombotic complications, but increases bleeding complication, after percutaneous coronary intervention (PCI) . Albeit without a universally recognized tool, current guidelines support weighting long‐term risk for both coronary thrombotic and bleeding events before the selection of DAPT duration .Most ischemic and bleeding risk models after PCI thus far have focused on in‐hospital or short‐term risk, and those focused on long‐term risk after coronary stent implantation have been derived and initially validated only in Western populations, despite their global nature, with the three major ones being: the stent thrombosis (ST) score [developed and internally validated by two randomized trials including the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS‐AMI) and acute catheterization and urgent intervention triage strategy (ACUITY) trials]; DAPT score [developed and internally validated by the dual antiplatelet therapy study and externally validated by the patient‐related outcomes with endeavor versus cypher stenting (PROTECT) study]; and PARIS score [developed and internally validated by the patterns of non‐adherence to anti‐platelet regimen in stented patients (PARIS) registry http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Catheterization and Cardiovascular Interventions Wiley

Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug‐eluting stent implantations

Loading next page...
 
/lp/wiley/validation-of-contemporary-risk-scores-in-predicting-coronary-dxFAwSw00R
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 Wiley Periodicals, Inc.
ISSN
1522-1946
eISSN
1522-726X
D.O.I.
10.1002/ccd.27468
Publisher site
See Article on Publisher Site

Abstract

AbbreviationsACSacute coronary syndromeCTEcoronary thrombotic eventsDAPTdual‐antiplatelet therapyMACEmajor adverse cardiovascular eventsMACCEmajor adverse cardiac and cerebral eventsMBmajor bleedingNSTEMInon‐ST‐segment elevation myocardial infarctionPCIpercutaneous coronary interventionSTstent thrombosisSTEMIST‐segment elevation myocardial infarctionINTRODUCTIONDual‐antiplatelet therapy (DAPT) with aspirin plus a P2Y12 inhibitor reduces thrombotic complications, but increases bleeding complication, after percutaneous coronary intervention (PCI) . Albeit without a universally recognized tool, current guidelines support weighting long‐term risk for both coronary thrombotic and bleeding events before the selection of DAPT duration .Most ischemic and bleeding risk models after PCI thus far have focused on in‐hospital or short‐term risk, and those focused on long‐term risk after coronary stent implantation have been derived and initially validated only in Western populations, despite their global nature, with the three major ones being: the stent thrombosis (ST) score [developed and internally validated by two randomized trials including the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS‐AMI) and acute catheterization and urgent intervention triage strategy (ACUITY) trials]; DAPT score [developed and internally validated by the dual antiplatelet therapy study and externally validated by the patient‐related outcomes with endeavor versus cypher stenting (PROTECT) study]; and PARIS score [developed and internally validated by the patterns of non‐adherence to anti‐platelet regimen in stented patients (PARIS) registry

Journal

Catheterization and Cardiovascular InterventionsWiley

Published: Jan 15, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial